The progressive decrease of TIGAR expression reported here is in agreement with the findings of altered post-translational modification of TP53, which result in increased formation of functionally inactive TP53 monomers and dimers, but not functionally active TP53 tetramers in AD brains [54]. The gene discussed is TP53; the disease is Alzheimer disease.